Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism

NCT02159469 is registered in ClinicalTrials.gov with Antares Pharma Inc. as lead sponsor.

NCT NCT02159469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02159469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Lead sponsor
Antares Pharma Inc.
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2014
Completion date
November 30, 2015
Enrollment
150 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism